Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

November 18, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • COVID-19 DRUGS: NOW OBTAINED FROM COMPUTATIONAL MODELLING

Designing Influenza Vaccines Project at THSTI | Rs. 49,000 pm Salary

Tata Medical Center Cytogenetics Scientific Officer Recruitment

COVID-19 DRUGS: NOW OBTAINED FROM COMPUTATIONAL MODELLING
  • BiotechToday
  • World

COVID-19 DRUGS: NOW OBTAINED FROM COMPUTATIONAL MODELLING

bioxone March 2, 2021March 1, 2021

Prama Ghosh, Amity University Kolkata

A new mechanism to help scientists fight against COVID – 19 and find new treatments for the disease has been elaborated by a team of researchers at the University of Warwick. Movements in nearly 300 protein structures of the spike protein of the virus are simulated using computational modelling techniques, to develop promising drug targets for the virus and test whether the existing techniques can work against mutations or not. 

A part of the EUTOPIA community of European universities, the team modelled the flexibility and dynamics of all 287 protein structures for the SARS-CoV-2. It is believed that interference with the mobility of those proteins could pave a way to treat the virus. Researchers have identified the ‘hinge’ mechanism in the homotrimer spike protein that allows it to attach to the ACE2 enzyme in human cell membranes and deliver the infection using a tunnel which later causes the symptoms of Covid-19. Finding a suitable molecule to block this mechanism will rapidly help scientists to identify effective drugs against the virus. 

All the data, movies, structural information, detailing, deformations and movement for all 287 protein structures for Covid-19 are contained in the Protein Data Bank, accessible by anyone who wishes to study and investigate the same. The details of the protein flexibility modelling approach used to study the movement of the protein by recreating the protein structure as a computer model then simulating the same, is also stored in the Protein Data Bank. 

Although the method is time-consuming, it will help scientists to quickly test the effectiveness of existing treatments on mutations of the virus and thus, identify new mechanics to treat the same.

Also read: 2.5D Microscopy: Volumetric Projection for Quantitative Subcellular Analysis

Source: Rudolf A. Römer, Navodya S. Römer, A. Katrine Wallis. Flexibility and mobility of SARS-CoV-2-related protein structures. Scientific Reports, Feb. 19, 2021; DOI: 10.1038/s41598-021-82849-2

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged cell computational modelling CORONAVIRUS COVID – 19 homotrimer infection Mutations Protein Data Bank protein structure spike protein

One thought on “COVID-19 DRUGS: NOW OBTAINED FROM COMPUTATIONAL MODELLING”

  1. Pingback: VML: Insights into the improvement of functionality in damaged muscles - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

Tata Medical Center Cytogenetics Scientific Officer Recruitment

bioxone March 2, 2021

-Shristi Sharma, Team bioXone TMC Cytogenetics Jobs – Scientific Officer Recruitment. Tata Translational Cancer Research Center Recruitment BSc/MSc Cytogenetics Job Opening. BSc/MSc Life & Biological Sciences candidates are encouraged to apply: Cytogenetics – Scientific Officer/ Technologist The Cytogenetics Department handles more than 3000 samples each year that consist of peripheral blood, bone marrow, and also […]

Related Post

  • BiotechToday
  • World

Easy-Prime – A genome editing program

bioxone August 22, 2021August 22, 2021

Madhavi Bhatia, National Pharmaceutical Education and Research, Guwahati Genome-editing technologies have made genetic studies transform from traditional interventions to precise manipulations of the DNA sequences thus resulting in both simplicity and robust outcomes. There are various genome-editing technologies, the clustered regularly interspaced short palindromic repeats (CRISPR) systems are widely used. The standard CRISPR-Cas9 method introduces […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Catalase: Antioxidant Treatment for COVID-19

bioxone October 2, 2020October 1, 2020

-Thota Kanishka Rao, Amity University Kolkata Researchers have discovered that a drug, Catalase, might be the solution to the ongoing coronavirus pandemic. Catalase is a naturally occurring enzyme having the potential as a therapeutic drug treat COVID-19 symptom and suppress the replication of the virus inside the body. Catalase is produced naturally and employed by […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Mucormycosis: Rise In Covid Cases With Black Fungus Infection

bioxone May 8, 2021May 9, 2021

Sagnik Nag , Amity University, Kolkata Currently, India as a developing nation with an average population of 1.34 billion, is fighting a battle against the lethal Coronavirus. Swift and agile efforts to mitigate the health effects of COVID-19 by the state and central governments are yielding some positive results. This pandemic has been a catastrophe […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy